-
The measure, which would make it illegal to sell tobacco products to anyone born after January 1, 2009, has cleared its first hurdle in Parliament.
-
Casgevy is the first medicine licensed using the gene editing tool CRISPR. The approval could offer relief to thousands of people with the crippling illness in the U.K.
-
Rishi Sunak’s office said the incremental changes could almost completely phase out smoking in young people as soon as 2040.
-
Tobacco giant Philip Morris International is pivoting away from cigarettes. Part of its reinvention plan is to stop selling cigarettes in the United Kingdom in the next 10 years.
-
Professor Paul Elliott, director of the React program at Imperial’s School of Public Health, speculated that men gathering at homes and pubs to watch the European Championship was one reason for the trend.
-
Prime Minister Boris Johnson says most remaining restrictions may soon be gone. If the plan moves ahead, it would bring about the closest version of pre-pandemic normalcy in nearly a year-and-a-half.
-
Cases remain low in Spain, Germany and France, but health ministers there say the fast spread of the Delta coronavirus strain elsewhere shows a serious threat.
-
CEO Ugur Sahin said more study was needed, but because the proteins on the variant are 99% the same as the prevailing strains, BioNTech has “scientific confidence” in the vaccine.
-
This is the latest in a long history of gonorrhea developing resistance to antibiotics. It's the first global report of gonorrhea that is resistant to the two main drugs used to treat it.